New scan technique could spot lung trouble early in transplant patients

NCT ID NCT05866302

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a special CT scan analysis called parametric response mapping (PRM) can detect early signs of chronic lung disease in people who have had a stem cell transplant. Researchers will follow 375 patients for one year to see if PRM patterns predict lung function decline or survival. The goal is to improve monitoring and timing of treatment for lung complications after transplant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a new way to predict lung problems early in transplant patients, helping doctors intervene sooner.
What could go wrong
This is an observational study, not testing a treatment. It may not lead to direct benefits for participants, and the imaging technique might not prove reliable in larger groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS OBLITERANS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dana Farber

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02215, United States

  • Emory University

    NOT_YET_RECRUITING

    Atlanta, Georgia, 30322, United States

  • Fred Hutchinson Cancer Research Center

    RECRUITING

    Seattle, Washington, 98109, United States

  • MD Anderson

    NOT_YET_RECRUITING

    Houston, Texas, 77030, United States

  • Stanford Hospital

    RECRUITING

    Stanford, California, 94305, United States

  • The University of Michigan Cancer Center

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.